Sign Up to like & get
recommendations!
0
Published in 2020 at "Practical Neurology"
DOI: 10.1136/practneurol-2019-002464
Abstract: Immune checkpoint inhibitors have transformed the treatment of advanced malignancy, while increasing the risk of immune-related adverse events. A 56-year-old woman who had received nivolumab for stage 4 renal cell carcinoma subsequently developed altered behaviour,…
read more here.
Keywords:
autoimmune encephalitis;
immune checkpoint;
encephalitis associated;
ma2 antibodies ... See more keywords